COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #108 of 237
8/5 Late treatment study
Kalligeros et al., Journal of Global Antimicrobial Resistance, doi:10.1016/j.jgar.2020.07.018 (Peer Reviewed)
Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study
Source   PDF   Share   Tweet
Small retrospective database analysis of 36 patients receiving HCQ not showing significant differences. Confounding by indication is likely.

Kalligeros et al., 8/5/2020, retrospective, USA, North America, peer-reviewed, 13 authors.
risk of death, 67.0% higher, RR 1.67, p = 0.57, treatment 36, control 72.
Details of all 237 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit